keyword
https://read.qxmd.com/read/34490822/compliance-and-fidelity-with-an-injury-prevention-exercise-program-in-high-school-athletics
#21
JOURNAL ARTICLE
Mickey I Krug, Pamela M Vacek, Rebecca Choquette, Bruce D Beynnon, James R Slauterbeck
BACKGROUND: Use of injury prevention programs (IPPs) by high school athletes has increased but their success in reducing injury depends on program compliance and fidelity of exercise performance. HYPOTHESIS: Compliance with the 11+ IPP and exercise performance fidelity by high school athletic teams depend on sex, sport, and level of play. STUDY DESIGN: Secondary analyses of data from a randomized controlled trial (RCT). LEVEL OF EVIDENCE: Level 2...
September 7, 2021: Sports Health
https://read.qxmd.com/read/34355174/preoperative-imaging-of-glioblastoma-patients-using-hyperpolarized-13-c-pyruvate-potential-role-in-clinical-decision-making
#22
JOURNAL ARTICLE
Jun Chen, Toral R Patel, Marco C Pinho, Changho Choi, Crystal E Harrison, Jeannie D Baxter, Kelley Derner, Salvador Pena, Jeff Liticker, Jaffar Raza, Ronald G Hall, Galen D Reed, Chunyu Cai, Kimmo J Hatanpaa, James A Bankson, Robert M Bachoo, Craig R Malloy, Bruce E Mickey, Jae Mo Park
BACKGROUND: Glioblastoma remains incurable despite treatment with surgery, radiation therapy, and cytotoxic chemotherapy, prompting the search for a metabolic pathway unique to glioblastoma cells.13 C MR spectroscopic imaging with hyperpolarized pyruvate can demonstrate alterations in pyruvate metabolism in these tumors. METHODS: Three patients with diagnostic MRI suggestive of a glioblastoma were scanned at 3 T 1-2 days prior to tumor resection using a 13 C/1 H dual-frequency RF coil and a 13 C/1 H-integrated MR protocol, which consists of a series of 1 H MR sequences (T2 FLAIR, arterial spin labeling and contrast-enhanced [CE] T1 ) and 13 C spectroscopic imaging with hyperpolarized [1-13 C]pyruvate...
January 2021: Neuro-oncology advances
https://read.qxmd.com/read/33977579/spectral-fitting-strategy-to-overcome-the-overlap-between-2-hydroxyglutarate-and-lipid-resonances-at-2-25-ppm
#23
JOURNAL ARTICLE
Pegah Askari, Ivan E Dimitrov, Sandeep K Ganji, Vivek Tiwari, Michael Levy, Toral R Patel, Edward Pan, Bruce E Mickey, Craig R Malloy, Elizabeth A Maher, Changho Choi
PURPOSE: 1 H MRS provides a noninvasive tool for identifying mutations in isocitrate dehydrogenase (IDH). Quantification of the prominent 2-hydroxyglutarate (2HG) resonance at 2.25 ppm is often confounded by the lipid resonance at the same frequency in tumors with elevated lipids. We propose a new spectral fitting approach to separate these overlapped signals, therefore, improving 2HG evaluation. METHODS: TE 97 ms PRESS was acquired at 3T from 42 glioma patients...
October 2021: Magnetic Resonance in Medicine
https://read.qxmd.com/read/33006401/the-association-of-vestibular-schwannoma-volume-with-facial-nerve-outcomes-after-surgical-resection
#24
JOURNAL ARTICLE
Daniel E Killeen, Samuel L Barnett, Bruce E Mickey, Jacob B Hunter, Brandon Isaacson, Joe Walter Kutz
OBJECTIVE: To explore the relationship between tumor size and facial nerve outcomes following vestibular schwannoma (VS) resection. STUDY DESIGN: Single institutional retrospective chart review of all adult patients with untreated sporadic VS who underwent surgical resection from 2008 to 2018 with preoperative magnetic resonance imaging (MRI) and 1 year of follow-up. The primary outcome measure was facial nerve outcome as assessed by the House-Brackmann facial nerve grading system...
April 2021: Laryngoscope
https://read.qxmd.com/read/32957864/facial-nerve-outcomes-after-vestibular-schwannoma-microsurgical-resection-in-neurofibromatosis-type-2
#25
JOURNAL ARTICLE
Catherine Sobieski, Daniel E Killeen, Samuel L Barnett, Bruce E Mickey, Jacob B Hunter, Brandon Isaacson, Joe Walter Kutz
OBJECTIVE: The aim of this study is to investigate facial nerve outcomes after microsurgical resection in neurofibromatosis type 2 (NF2) compared to sporadic tumors. STUDY DESIGN: Single institutional retrospective chart review. SETTING: Tertiary referral center. METHODS: All adult patients with NF2 vestibular schwannoma (VS) or sporadic VS who underwent microsurgical resection from 2008 to 2019 with preoperative magnetic resonance imaging (MRI) and 1 year of postsurgical follow-up were included...
April 2021: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/32705083/a-novel-fully-automated-mri-based-deep-learning-method-for-classification-of-1p-19q-co-deletion-status-in-brain-gliomas
#26
JOURNAL ARTICLE
Chandan Ganesh Bangalore Yogananda, Bhavya R Shah, Frank F Yu, Marco C Pinho, Sahil S Nalawade, Gowtham K Murugesan, Benjamin C Wagner, Bruce Mickey, Toral R Patel, Baowei Fei, Ananth J Madhuranthakam, Joseph A Maldjian
BACKGROUND: One of the most important recent discoveries in brain glioma biology has been the identification of the isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion status as markers for therapy and prognosis. 1p/19q co-deletion is the defining genomic marker for oligodendrogliomas and confers a better prognosis and treatment response than gliomas without it. Our group has previously developed a highly accurate deep-learning network for determining IDH mutation status using T2-weighted (T2w) MRI only...
January 2020: Neuro-oncology advances
https://read.qxmd.com/read/32626590/extraneural-metastatic-anaplastic-ependymoma-a-systematic-review-and-a-report-of-metastases-to-bilateral-parotid-glands
#27
JOURNAL ARTICLE
Gray Umbach, Tarek Y El Ahmadieh, Aaron R Plitt, Salah G Aoun, Om J Neeley, Kristopher A Lyon, Ekokobe Fonkem, Jack M Raisanen, Justin A Bishop, Zabi Wardak, Toral R Patel, Larry Myers, Bruce E Mickey
BACKGROUND: Anaplastic ependymoma with extraneural metastases is associated with a poor clinical outcome. Metastatic spread to the parotid gland is a rare clinical entity that requires multidisciplinary intervention. Herein, we present a systematic review of anaplastic ependymoma with extraneural metastases and report on a case with metastases to both parotid glands. METHODS: Electronic databases were searched from their inception to February 2019. Inclusion criteria included reports of anaplastic ependymoma with extraneural metastasis...
March 2020: Neuro-oncology Practice
https://read.qxmd.com/read/32352337/implementation-of-the-fifa-11-injury-prevention-program-by-high-school-athletic-teams-did-not-reduce-lower-extremity-injuries-response
#28
JOURNAL ARTICLE
Bruce D Beynnon, Pamela Vacek, Timothy W Tourville, Rebecca Choquette, Chongyang Wang, Mickey Krug, James R Slauterbeck
No abstract text is available yet for this article.
May 2020: American Journal of Sports Medicine
https://read.qxmd.com/read/32055850/glycine-by-mr-spectroscopy-is-an-imaging-biomarker-of-glioma-aggressiveness
#29
JOURNAL ARTICLE
Vivek Tiwari, Elena V Daoud, Kimmo J Hatanpaa, Ang Gao, Song Zhang, Zhongxu An, Sandeep K Ganji, Jack M Raisanen, Cheryl M Lewis, Pegah Askari, Jeannie Baxter, Michael Levy, Ivan Dimitrov, Binu P Thomas, Marco C Pinho, Christopher J Madden, Edward Pan, Toral R Patel, Ralph J DeBerardinis, A Dean Sherry, Bruce E Mickey, Craig R Malloy, Elizabeth A Maher, Changho Choi
BACKGROUND: High-grade gliomas likely remodel the metabolic machinery to meet the increased demands for amino acids and nucleotides during rapid cell proliferation. Glycine, a non-essential amino acid and intermediate of nucleotide biosynthesis, may increase with proliferation. Non-invasive measurement of glycine by magnetic resonance spectroscopy (MRS) was evaluated as an imaging biomarker for assessment of tumor aggressiveness. METHODS: We measured glycine, 2-hydroxyglutarate (2HG), and other tumor-related metabolites in 35 glioma patients using an MRS sequence tailored for co-detection of glycine and 2HG in gadolinium-enhancing and non-enhancing tumor regions on 3T MRI...
July 7, 2020: Neuro-oncology
https://read.qxmd.com/read/32003035/in-vivo-mrs-measurement-of-2-hydroxyglutarate-in-patient-derived-idh-mutant-xenograft-mouse-models-versus-glioma-patients
#30
JOURNAL ARTICLE
Vivek Tiwari, Tomoyuki Mashimo, Zhongxu An, Vamsidhara Vemireddy, Sara Piccirillo, Pegah Askari, Keith M Hulsey, Shanrong Zhang, Robin A de Graaf, Toral R Patel, Edward Pan, Bruce E Mickey, Elizabeth A Maher, Robert M Bachoo, Changho Choi
PURPOSE: To generate a preclinical model of isocitrate dehydrogenase (IDH) mutant gliomas from glioma patients and design a MRS method to test the compatibility of 2-hydroxyglutarate (2HG) production between the preclinical model and patients. METHODS: Five patient-derived xenograft (PDX) mice were generated from two glioma patients with IDH1 R132H mutation. A PRESS sequence was tailored at 9.4 T, with computer simulation and phantom analyses, for improving 2HG detection in mice...
September 2020: Magnetic Resonance in Medicine
https://read.qxmd.com/read/31824982/classification-of-brain-tumor-isocitrate-dehydrogenase-status-using-mri-and-deep-learning
#31
JOURNAL ARTICLE
Sahil Nalawade, Gowtham K Murugesan, Maryam Vejdani-Jahromi, Ryan A Fisicaro, Chandan G Bangalore Yogananda, Ben Wagner, Bruce Mickey, Elizabeth Maher, Marco C Pinho, Baowei Fei, Ananth J Madhuranthakam, Joseph A Maldjian
Isocitrate dehydrogenase (IDH) mutation status is an important marker in glioma diagnosis and therapy. We propose an automated pipeline for noninvasively predicting IDH status using deep learning and T2-weighted (T2w) magnetic resonance (MR) images with minimal preprocessing (N4 bias correction and normalization to zero mean and unit variance). T2w MR images and genomic data were obtained from The Cancer Imaging Archive dataset for 260 subjects (120 high-grade and 140 low-grade gliomas). A fully automated two-dimensional densely connected model was trained to classify IDH mutation status on 208 subjects and tested on another held-out set of 52 subjects using fivefold cross validation...
October 2019: Journal of Medical Imaging
https://read.qxmd.com/read/31637430/a-novel-fully-automated-mri-based-deep-learning-method-for-classification-of-idh-mutation-status-in-brain-gliomas
#32
JOURNAL ARTICLE
Chandan Ganesh Bangalore Yogananda, Bhavya R Shah, Maryam Vejdani-Jahromi, Sahil S Nalawade, Gowtham K Murugesan, Frank F Yu, Marco C Pinho, Benjamin C Wagner, Bruce Mickey, Toral R Patel, Baowei Fei, Ananth J Madhuranthakam, Joseph A Maldjian
BACKGROUND: Isocitrate dehydrogenase (IDH) mutation status has emerged as an important prognostic marker in gliomas. Currently, reliable IDH mutation determination requires invasive surgical procedures. The purpose of this study was to develop a highly accurate, MRI-based, voxelwise deep-learning IDH classification network using T2-weighted (T2w) MR images and compare its performance to a multicontrast network. METHODS: Multiparametric brain MRI data and corresponding genomic information were obtained for 214 subjects (94 IDH-mutated, 120 IDH wild-type) from The Cancer Imaging Archive and The Cancer Genome Atlas...
March 5, 2020: Neuro-oncology
https://read.qxmd.com/read/31634366/considerations-of-target-surface-area-and-the-risk-of-radiosurgical-toxicity
#33
JOURNAL ARTICLE
Strahinja Stojadinovic, Yulong Yan, Andrew Leiker, Chul Ahn, Zabi Wardak, Tu Dan, Lucien Nedzi, Robert Timmerman, Toral Patel, Samuel Barnett, Bruce Mickey, Jeffrey Meyer
OBJECTIVE: The goal of this study was to explore conceptual benefits of characterizing delineated target volumes based on surface area and to utilize the concept for assessing risk of therapeutic toxicity in radiosurgery. METHODS AND MATERIALS: Four computer-generated targets, a sphere, a cylinder, an ellipsoid and a box, were designed for two distinct scenarios. In the first scenario, all targets had identical volumes, and in the second one, all targets had identical surface areas...
2019: PloS One
https://read.qxmd.com/read/31526276/implementation-of-the-fifa-11-injury-prevention-program-by-high-school-athletic-teams-did-not-reduce-lower-extremity-injuries-a-cluster-randomized-controlled-trial
#34
RANDOMIZED CONTROLLED TRIAL
James R Slauterbeck, Rebecca Choquette, Timothy W Tourville, Mickey Krug, Bert R Mandelbaum, Pamela Vacek, Bruce D Beynnon
BACKGROUND: Lower extremity injuries are common in high school sports and are costly, and some have poor outcomes. The FIFA 11+ injury prevention program has been shown to decrease injuries in elite athletes by up to 72%. HYPOTHESIS: High schools in which coaches implement the FIFA 11+ injury prevention program in their athletic programs will have a decreased incidence of lower extremity injuries compared with schools using their usual prepractice warm-up. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1...
October 2019: American Journal of Sports Medicine
https://read.qxmd.com/read/31421300/dysembryoplastic-neuroepithelial-tumor-with-an-enlarging-heterogeneously-enhancing-organizing-hematoma
#35
JOURNAL ARTICLE
Tarek Y El Ahmadieh, Chunyu Cai, Bruce E Mickey
This report portrays an unusual presentation of a dysembryoplastic neuroepithelial tumor characterized by a chronic, enlarging, heterogeneously enhancing organizing hematoma. Differential diagnoses included the malignant transformation of a low-grade glioma, radiation necrosis, and radiation-induced cavernoma. DNT may have atypical characteristics and behavior, therefore, continued follow-up with serial imaging is recommended.
August 14, 2019: World Neurosurgery
https://read.qxmd.com/read/31363754/efficacy-of-egfr-plus-tnf-inhibition-in-a-preclinical-model-of-temozolomide-resistant-glioblastoma
#36
JOURNAL ARTICLE
Gao Guo, Ke Gong, Vineshkumar Thidil Puliyappadamba, Nishah Panchani, Edward Pan, Bipasha Mukherjee, Ziba Damanwalla, Sabrina Bharia, Kimmo J Hatanpaa, David E Gerber, Bruce E Mickey, Toral R Patel, Jann N Sarkaria, Dawen Zhao, Sandeep Burma, Amyn A Habib
BACKGROUND: Glioblastoma (GBM) is the most common primary malignant adult brain tumor. Temozolomide (TMZ) is the standard of care and is most effective in GBMs that lack the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT). Moreover, even initially responsive tumors develop a secondary resistance to TMZ and become untreatable. Since aberrant epidermal growth factor receptor (EGFR) signaling is widespread in GBM, EGFR inhibition has been tried in multiple clinical trials without success...
December 17, 2019: Neuro-oncology
https://read.qxmd.com/read/31034050/genome-wide-analysis-of-glioblastoma-patients-with-unexpectedly-long-survival
#37
JOURNAL ARTICLE
Timothy E Richardson, Seema Patel, Jonathan Serrano, Adwait Amod Sathe, Elena V Daoud, Dwight Oliver, Elizabeth A Maher, Alejandra Madrigales, Bruce E Mickey, Timothy Taxter, George Jour, Charles L White, Jack M Raisanen, Chao Xing, Matija Snuderl, Kimmo J Hatanpaa
Glioblastoma (GBM), representing WHO grade IV astrocytoma, is a relatively common primary brain tumor in adults with an exceptionally dismal prognosis. With an incidence rate of over 10 000 cases in the United States annually, the median survival rate ranges from 10-15 months in IDH1/2-wildtype tumors and 24-31 months in IDH1/2-mutant tumors, with further variation depending on factors such as age, MGMT methylation status, and treatment regimen. We present a cohort of 4 patients, aged 37-60 at initial diagnosis, with IDH1-mutant GBMs that were associated with unusually long survival intervals after the initial diagnosis, currently ranging from 90 to 154 months (all still alive)...
June 1, 2019: Journal of Neuropathology and Experimental Neurology
https://read.qxmd.com/read/30595522/stereotactic-radiosurgery-for-multiple-brain-metastases-from-renal-cell-carcinoma
#38
JOURNAL ARTICLE
Zabi Wardak, Alana Christie, Alex Bowman, Strahinja Stojadinovic, Lucien Nedzi, Sam Barnett, Toral Patel, Bruce Mickey, Tony Whitworth, Raquibul Hannan, James Brugarolas, Robert Timmerman
BACKGROUND: Brain metastases (BM) pose a significant problem in patients with metastatic renal-cell carcinoma (mRCC). Local and systemic therapies including stereotactic radiosurgery (SRS) are rapidly evolving, necessitating reassessments of outcomes for modern patient management. PATIENTS AND METHODS: The mRCC patients with BM treated with SRS were reviewed. Patient demographics, clinical history, and SRS treatment parameters were identified. RESULTS: Among 268 patients with mRCC treated between 2006 and 2015, 38 patients were identified with BM...
November 22, 2018: Clinical Genitourinary Cancer
https://read.qxmd.com/read/30538068/improved-survival-outcomes-for-kidney-cancer-patients-with-brain-metastases
#39
JOURNAL ARTICLE
I Alex Bowman, Alisha Bent, Tri Le, Alana Christie, Zabi Wardak, Yull Arriaga, Kevin Courtney, Hans Hammers, Samuel Barnett, Bruce Mickey, Toral Patel, Tony Whitworth, Strahinja Stojadinovic, Raquibul Hannan, Lucien Nedzi, Robert Timmerman, James Brugarolas
BACKGROUND: Brain metastases (BM) occur frequently in patients with metastatic kidney cancer and are a significant source of morbidity and mortality. Although historically associated with a poor prognosis, survival outcomes for patients in the modern era are incompletely characterized. In particular, outcomes after adjusting for systemic therapy administration and International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk factors are not well-known. PATIENTS AND METHODS: A retrospective database of patients with metastatic renal cell carcinoma (RCC) treated at University of Texas Southwestern Medical Center between 2006 and 2015 was created...
December 5, 2018: Clinical Genitourinary Cancer
https://read.qxmd.com/read/30503286/intraspinal-dissemination-and-local-recurrence-of-an-intracranial-hemangiopericytoma-case-report
#40
JOURNAL ARTICLE
Heather N Hayenga, Andrew J Bishop, Zabi Wardak, Chandra Sen, Bruce Mickey
BACKGROUND: Hemangiopericytomas (HPCs) are rare vascular tumors that resemble meningiomas on imaging and have a high rate of local recurrence and metastases. There remains a paucity of data to guide management decisions of intraspinal dissemination of HPC in the literature, and none specifically related to anaplastic HPCs. CASE DESCRIPTION: Case report of a 34-year-old female with locally and distantly recurrent anaplastic hemangiopericytoma (HPC) (WHO grade III)...
November 29, 2018: World Neurosurgery
keyword
keyword
13339
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.